The need for strong, self-regulation for the sales of essential oils was reinforced by the recent FDA WARNING LETTERS sent to dōTERRA and Young Living in September 2014.

Independent Salespeople from these companies have been misleading consumers for too long. Dangerous claims and unsafe usage advice have led to horrific stories of liver failure, chemical burns, and hospitalizations. [See examples from the recent injury data collection: http://aromatherapyunited.wordpress.com/category/injury-reports-2014/]

The marketing claims made by these companies and their salespeople are dangerous. They are not selling essential oils with truthful sales and marketing claims.

Peoples health and safety are at risk when a salesperson tells them they should use essential oils to treat Ebola, protect against Tetanus, cure Parkinson’s, prevent Alzheimer’s, fix Autism or Brain Injury or cure Breast Cancer. Unless we self-regulate as an industry, the burden will fall to the FDA whose actions will effect us all.

“Your products, “Thieves,” “Cinnamon Bark,” “Oregano,” “ImmuPower,” “Rosemary,” “Myrtle,” “Sandalwood,” “Eucalyptus Blue,” “Peppermint,” “Ylang Ylang,” “Frankincense,” and “Orange,” are prescription drugs as defined in section 503(b)(1)(A) of the Act [21 U.S.C. § 353(b)(1)(A)] for some of the claims made for them because, in light of their toxicity or other potentiality for harmful effect, the method of their use, or the collateral measures necessary to their use, they are not safe for use except under the supervision of a practitioner licensed by law to administer it.” – FDA Warning Letter sent to Young Living

We need to act quickly before the actions of these companies force the FDA into a corner and they decide that essential oils SHOULD be PRESCRIPTION DRUGS!

CNN reported the U.S. Food and Drug Administration states:

“We have a program at FDA that monitors the Internet to look for health fraud products, products not approved by FDA that claim to cure or treat disease,” said Howard Sklamberg, the FDA’s deputy commissioner for global regulatory operations and policy.”

 

“We are continuing to monitor the internet and monitor how these three companies respond,” Sklamberg said. “They have 15 working days to take corrective action. If they don’t take the corrective action, we can take enforcement action against them…seizure, injunction, criminal prosecution.” – CNN http://www.cnn.com/2014/09/26/health/ebola-fake-drugs/

Every time a salesperson makes a dangerous and illegal medical claim such as those examples in the FDA WARNING LETTERS, the entire essential oil industry is put at risk of increased FDA regulations.